I
Insmed
IPO- Headquarters
- Bridgewater, New Jersey
- Employees
- 1001–5000
- Business Model
- B2B
- Type
- Public
About
Global biopharmaceutical company developing first- and best-in-class therapies for patients with serious rare diseases.
Similar Companies
Simtra BioPharma Solutions
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Bloomington, United States1001–5000Biotech, Contract Manufacturing
Private Equity·$4.3B·Oct 2023
Isomorphic Labs
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
London, United Kingdom201–500Artificial Intelligence, Biotech
Venture Unknown·$3.2B·May 2026
inVentiv HealthAcquired
Biopharmaceutical services company
United States5001–10000Biotech, Healthcare
Private Equity·$3.0B·May 2017
WC
Warner ChilcottAcquired
Specialty pharmaceutical company
Rockaway, United States1001–5000Biotech, Healthcare
Private Equity·$3.0B·Jan 2004
Impossible Foods
Food technology company creating plant-based meat and dairy products that replicate the taste and...
Redwood City, United States501–1000Agtech, Biotech
Series G Plus·$2.4B·Nov 2021
AsymchemIPO
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Tianjin, China5001–10000Healthcare, Biotech
Private Equity·$2.3B·Feb 2020